This European project aims to overcome the limitations caused by a lack of reference measurement procedures for established Alzheimer's disease (AD) biomarkers in cerebrospinal fluid (CSF), while also introducing reference measurement procedures for potential new blood-based AD biomarkers, such as metals and metalloproteins. The traceability of the provided reference measurement procedures will provide comparability between laboratories.